Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice.

In this study, the impact of infection stage on clinically and microbiologically efficacious doses and on antibiotic consumption was assessed during a naturally evolving infectious disease, using an original mouse model of pulmonary infection produced by air-borne contamination. When Pasteurella mul...

Full description

Bibliographic Details
Main Authors: Maleck V Vasseur, Marlene Z Lacroix, Pierre-Louis Toutain, Alain Bousquet-Melou, Aude A Ferran
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5544235?pdf=render
id doaj-5e2cd291b0fc49ee95f216e01d352d75
record_format Article
spelling doaj-5e2cd291b0fc49ee95f216e01d352d752020-11-25T02:29:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018286310.1371/journal.pone.0182863Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice.Maleck V VasseurMarlene Z LacroixPierre-Louis ToutainAlain Bousquet-MelouAude A FerranIn this study, the impact of infection stage on clinically and microbiologically efficacious doses and on antibiotic consumption was assessed during a naturally evolving infectious disease, using an original mouse model of pulmonary infection produced by air-borne contamination. When Pasteurella multocida was administered as pathogenic agent to immunocompetent mice, 60% of the animals exhibited clinical symptoms of pneumonia 2 to 4 days after bacterial contamination of the lungs. Two beta-lactam antibiotics were evaluated: amoxicillin and cefquinome, a fourth generation cephalosporin developed for food animals. First, a pharmacokinetic study was performed in infected mice to determine the exposure to amoxicillin or cefquinome required to treat clinically affected animals, based on the targeted values of PK/PD indices for beta-lactams. We then confirmed that these doses resulted in a 100% clinical cure rate in animals exhibiting clinical signs of infection and harboring a high pathogenic inoculum. More interestingly, we also showed that the same 100% clinical cure could be obtained in our model with 10-fold lower doses in animals at pre-patent stages of infection i.e. when harboring a low pathogenic inoculum. At the group level, antimicrobial drug consumption was reduced by treating animals at an early stage of the infection course with a pre-patent tailored dose. These results suggest that early treatment with a dose suitably adjusted to the stage of infection might help to reduce both overall antibiotic consumption and resistance selection pressure in the animals and in the environment.http://europepmc.org/articles/PMC5544235?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Maleck V Vasseur
Marlene Z Lacroix
Pierre-Louis Toutain
Alain Bousquet-Melou
Aude A Ferran
spellingShingle Maleck V Vasseur
Marlene Z Lacroix
Pierre-Louis Toutain
Alain Bousquet-Melou
Aude A Ferran
Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice.
PLoS ONE
author_facet Maleck V Vasseur
Marlene Z Lacroix
Pierre-Louis Toutain
Alain Bousquet-Melou
Aude A Ferran
author_sort Maleck V Vasseur
title Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice.
title_short Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice.
title_full Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice.
title_fullStr Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice.
title_full_unstemmed Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice.
title_sort infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: a pasteurella multocida experimental pneumonia in mice.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description In this study, the impact of infection stage on clinically and microbiologically efficacious doses and on antibiotic consumption was assessed during a naturally evolving infectious disease, using an original mouse model of pulmonary infection produced by air-borne contamination. When Pasteurella multocida was administered as pathogenic agent to immunocompetent mice, 60% of the animals exhibited clinical symptoms of pneumonia 2 to 4 days after bacterial contamination of the lungs. Two beta-lactam antibiotics were evaluated: amoxicillin and cefquinome, a fourth generation cephalosporin developed for food animals. First, a pharmacokinetic study was performed in infected mice to determine the exposure to amoxicillin or cefquinome required to treat clinically affected animals, based on the targeted values of PK/PD indices for beta-lactams. We then confirmed that these doses resulted in a 100% clinical cure rate in animals exhibiting clinical signs of infection and harboring a high pathogenic inoculum. More interestingly, we also showed that the same 100% clinical cure could be obtained in our model with 10-fold lower doses in animals at pre-patent stages of infection i.e. when harboring a low pathogenic inoculum. At the group level, antimicrobial drug consumption was reduced by treating animals at an early stage of the infection course with a pre-patent tailored dose. These results suggest that early treatment with a dose suitably adjusted to the stage of infection might help to reduce both overall antibiotic consumption and resistance selection pressure in the animals and in the environment.
url http://europepmc.org/articles/PMC5544235?pdf=render
work_keys_str_mv AT maleckvvasseur infectionstageadjusteddoseofbetalactamsforparsimoniousandefficientantibiotictreatmentsapasteurellamultocidaexperimentalpneumoniainmice
AT marlenezlacroix infectionstageadjusteddoseofbetalactamsforparsimoniousandefficientantibiotictreatmentsapasteurellamultocidaexperimentalpneumoniainmice
AT pierrelouistoutain infectionstageadjusteddoseofbetalactamsforparsimoniousandefficientantibiotictreatmentsapasteurellamultocidaexperimentalpneumoniainmice
AT alainbousquetmelou infectionstageadjusteddoseofbetalactamsforparsimoniousandefficientantibiotictreatmentsapasteurellamultocidaexperimentalpneumoniainmice
AT audeaferran infectionstageadjusteddoseofbetalactamsforparsimoniousandefficientantibiotictreatmentsapasteurellamultocidaexperimentalpneumoniainmice
_version_ 1724834434476146688